These results are in line with the observations that the survival rate of Vav1-positive human primary pancreatic adenocarcinomas was worse than that of Vav1-negative tumors (Fernandez-Zapico et al, 2005; Huang et al, 2016). The gene discussed is VAV1; the disease is pancreatic adenocarcinoma.